Outcomes
psychiatric
ADVERSE EVENTS, SECONDARY
Participant outcome data were collected at or shortly after consent and at a single follow-up point. Follow-up was originally planned to be 10 months (±1 month) after randomisation of the practice. The anticipated operational problems of following up the high number of individuals recruited in the final month (The primary outcome measure was quality of life as measured by change in score on the participant-reported Manchester Short Assessment of Quality of Life (MANSA) version 2,Participant-reported secondary outcomes collected at baseline and follow-up were the Time Use Survey (TUS; assessing time in structured activity),Data about mental healthcare service use were collected from secondary care records. Safety outcomes, analysed from the date of practice unmasking (randomisation) through to 10 months after randomisation, were the number of psychiatric hospital admissions, number of in-patient days as a result of psychiatric admission, number of episodes under home treatment (crisis care) and total days under home treatment (crisis care). Details of serious adverse events (e.g. hospital admissions) were also collected after identification during follow-up by researchers and/or practitioners during routine or PARTNERS care.